Diabetes drug put to the test: can it heal blood vessels from the inside?
NCT ID NCT04126603
Summary
This study aimed to understand how the approved diabetes medication semaglutide affects two specific types of cells in people with type 2 diabetes. Researchers tested whether the drug could improve the health and function of cells that repair blood vessels and cells found in fat tissue. Ten participants were given either semaglutide or a placebo for 24 weeks, and researchers analyzed blood and fat tissue samples to look for changes in these cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The GW Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
-
Washington VA Medical Center
Washington D.C., District of Columbia, 20422, United States
Conditions
Explore the condition pages connected to this study.